Publications

Animal Testing Landscape 2025

About this white paper

Animal testing has played a crucial role in medical advancements, leading to major discoveries that have saved countless lives.

However, today, more accurate, cost-effective and ethical alternatives are available. Regulatory developments remain too slow to really decrease the number of animals being used.

After months of work, we are proud to share with you our white paper on animal testing.

The goal of this document is to give an overview on the use of animal in scientific experimentations :

  • How many animals are used ?
  • What kinds of animals ?
  • Which industries use the most animals ?
  • What happens to them after the tests ?
  • What are the alternatives ?

And many more answers to understand what is going on.

Happy reading and if you find it’s useful, share it to boost the impact.

Animal testing landscape-2025-Cherry-Biotech-cover

Full version

This document has been funded by The European Union, under the grant agreement n° 101046928 & 101046928

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.

EIC

Related Posts

Diagram of a triple-negative breast cancer cell showing absence of ER, PR, and HER2 receptors, representing the defining features of TNBC and its lack of conventional therapeutic targets.
Triple-Negative Breast Cancer and the Application of Breast Cance...
Triple-negative breast cancer (TNBC) is a distinct pathological subtype defined by the absence of estrogen receptor (ER), progesterone recep...
Read more
3d-cell-culture-adipocytes-cubix
OOCHIP: Compartmentalized Microfluidic Perfusion System with Poro...
Abstract (Ramadan et al) : Improved in vitro models of human organs for predicting drug efficacy, interactions, and disease modeling are c...
Read more
Clear drug vial labeled mAb next to a blue circular stamp reading FDA approve
How breast cancer organoids can accelerate ongoing clinical trial...
Introduction Microphysiological systems (MPS) are fast becoming a cornerstone of FDA-aligned non-clinical strategy, especially when paired w...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy
×

Our Associated Solutions

Banner

Need to quickly generate results? Our ready to use AdipoPlates are perfect for you!

Discover our AdipoPlate
×

Contact Us!

Aside

We're happy to answer any questions you may have. Reach out to our team for assistance.

Contact Now